|
purK protein, E coli
|
C075015 |
|
|
5-(N-(N-biotinyl-epsilon-aminocaproyl)-3-aminoallyl)-2'-deoxuridine 5'-triphosphate
|
C075017 |
|
|
Zn(II)-DpaTyr
|
C521584 |
|
|
5-ethoxy-1-phenyl-1H-tetrazole
|
C521585 |
|
|
tricarbonylchlorobis(4-styrylpyridine)rhenium(II)
|
C521586 |
|
|
tricarbonyl(2,2'-bipyridine)(4-styrylpyridine)rhenium(II)
|
C521587 |
|
|
erucylphosphocholine
|
C075010 |
|
|
poly(amino ester glycol urethane)
|
C521588 |
|
|
Transfusion Reaction
|
D065227 |
[Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.
] |
|
sulfobetaine methacrylate polymer
|
C521589 |
|
|
Non-Randomized Controlled Trials as Topic
|
D065228 |
[Works about a study where participants are assigned to a treatment, procedure, or intervention by methods that are not random. Non-randomized clinical trials are sometimes referred to as quasi-experimental clinical trials or non-equivalent control group designs.
] |
|
rilmakalim
|
C075012 |
|
|
Kif4 protein, mouse
|
C089655 |
|
|
JM 335
|
C089656 |
|
|
arcyriaflavin A
|
C089657 |
|
|
small multidrug-resistance pump, Staphylococcus aureus
|
C521590 |
|
|
2-chlorocrotonaldehyde
|
C089659 |
|
|
TraO protein, E coli
|
C521591 |
|
|
Nsp1 protein, SARS coronavirus
|
C521592 |
|
|
alpha-ethylbenzyl phenyl sulfide
|
C521593 |
|
